- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06264856
Bronchoscopy for Thoracic Trauma Patients
Flexible-bronchoscopy Trial for Moderate and Severe Thoracic Trauma Patients Without Brain Injury
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 10002
- Department of Traumatology, National Taiwain University Hospital
-
Taipei, Taiwan, 100; 300; 640; 280
- NTUH Hsin-Chu Branch; NTUH Yun-Lin Branch
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants must be 20 years of age or older.
- Participants of all genders are eligible.
- Participants who are not in good health are not eligible.
- Participants with an Injury Severity Score greater than 9 and who have chest trauma are eligible.
Exclusion Criteria:
- Patients with traumatic brain injury.
- Patients with active pulmonary tuberculosis or other respiratory diseases with suspected contagion.
- Patients with poor blood clotting function or a tendency to bleed.
- Patients with aortic aneurysm. Patients with unstable vital signs or those who cannot maintain oxygen saturation above 90% while performing the test with Fraction of Inspired Oxygen (FiO2) greater than 80% or on 100% oxygen.
- Immunocompromised patients.
- Patients with acute massive hemoptysis.
- Patients with pre-existing neuromuscular diseases or those at high risk for arrhythmias, myocardial ischemia, or pulmonary embolism.
- Patients who are unable to clearly express their willingness to sign the informed consent form.
- Patients who have frequent intermittent sputum suction or are unable to fast for 4 hours due to their medical condition.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: bronchoscopic suction
Bronchoscopic suction is a medical procedure used to remove excess mucus, secretions, and foreign objects from the airways through a bronchoscope.
The patient would receive bronchoscopic sputum suction every 24-48 hrs after randomization until leaving ICU..
The patient could still receive blind negative pressure aspiration suction as the usual medical routine(every 2-4 hrs sputum suction if needed).
|
Bronchoscopy is a medical procedure in which a flexible tube called a bronchoscope is passed through the mouth or nose and into the lungs. Bronchoscopic suction is a technique used during bronchoscopy to remove secretions, mucus, or foreign objects from the airways. The bronchoscope is equipped with a suction port and a suction channel that allows the doctor to remove fluids or other material from the airways. The suction port is connected to a vacuum source, and the suction channel runs through the bronchoscope and terminates at the tip of the instrument. |
|
Active Comparator: blind negative pressure aspiration suction
Negative pressure aspiration suction is a medical procedure that uses suction to remove fluids, mucus, or other materials from the body by creating a negative pressure or vacuum.
The procedure involves inserting a catheter into the airway and applying negative pressure to the catheter to suction out the secretions or fluids.
The patient would receive blind negative pressure aspiration suction as the usual medical routine(every 2-4 hrs sputum suction if needed).
|
The procedure involves inserting a catheter into the airway and applying negative pressure to the catheter to suction out the secretions or fluids.
The patient could receive sputum suction as medical routine (every 2-4 hrs) if needed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of pneumonia
Time Frame: 30 days after randomization
|
diagnosis of pneumonia was determined according to radiologic evidence of new or progressive infiltrate of more than 48 hours and laboratory detection of a causative agent. The management and diagnosis of all patients was performed by a trauma specialist. |
30 days after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intensive Care Unit admission interval
Time Frame: 30 days
|
measure the time of total Intensive Care Unit admission interval
|
30 days
|
|
admission interval
Time Frame: up to 24 weeks (from randomization to discharge)
|
measure the time of total admission interval
|
up to 24 weeks (from randomization to discharge)
|
|
tracheostomy rate
Time Frame: up to 24 weeks (from randomization to discharge)
|
measure the rate of patient who receive tracheostomy in this admission
|
up to 24 weeks (from randomization to discharge)
|
|
intubation rate
Time Frame: 90 days
|
measure the rate of intubation rate
|
90 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Hsien-Chi Liao, MD, Department of Traumatology, National Taiwain University Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202210096RIND
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chest Trauma
-
Hospital de GranollersCompleted
-
Sohag UniversityNot yet recruitingChest Trauma PatientsEgypt
-
Radboud University Medical CenterRecruitingBlunt Chest TraumaNetherlands
-
Assiut UniversityNot yet recruitingChest Injury Trauma
-
Al-Nahrain UniversityNot yet recruitingChest Injury Trauma BluntIraq
-
Peking University People's HospitalNot yet recruiting
-
Shanghai Jiao Tong University Affiliated Sixth...CompletedPulmonary Contusion , Chest Trauma , Prediction Model
-
Azienda Usl di BolognaAzienda ospedaliera universitaria Careggi; Ospedale di Circolo e Fondazione... and other collaboratorsRecruiting
-
Al-Nahrain UniversityRecruiting
Clinical Trials on bronchoscopic sputum suction
-
University of Southern DenmarkCompleted
-
Affiliated Hospital of Nantong UniversityRecruiting
-
National Cancer Institute (NCI)CompletedHead and Neck Cancer | Lung CancerUnited States
-
Shanghai Zhongshan HospitalUnknownNeoplasms | Lymphoma | Inflammation | Cancer | Infection | Sarcoid | Mass LesionChina
-
Izmir Katip Celebi UniversityRecruiting
-
Broncus TechnologiesHeidelberg UniversityUnknown
-
Changhai HospitalNot yet recruiting
-
Nordsjaellands HospitalCompleted
-
King Abdulaziz UniversityCompletedInfections | Oral InfectionSaudi Arabia
-
University of Cape TownCompleted